Stabilisation of growth hormones in solution

Details for Australian Patent Application No. 2004222528 (hide)

Owner Ares Trading S.A.

Inventors Donati, Piergiorgio; Samaritani, Fabrizio

Agent Griffith Hack

Pub. Number AU-B-2004222528

PCT Pub. Number WO2004/082707

Priority 03100678.6 18.03.03 EP

Filing date 11 March 2004

Wipo publication date 30 September 2004

Acceptance publication date 11 February 2010

International Classifications

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/25 (2006.01) Medicinal preparations containing peptides - Growth hormone-releasing factor (GH-RF) (Somatoliberin)

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/082707 Priority application(s): WO2004/082707

29 June 2006 Change of Name(s) of Applicant(s), Section 104

  Ares Trading SA The name of the applicant has been changed to Ares Trading S.A.

11 February 2010 Application Accepted

  Published as AU-B-2004222528

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222529-INF-beta alone or in combination with other medicaments for treating Alzheimer's disease and demens disorders

2004222527-Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor